Back to LCTX
Defender Capital, LLC. LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
4
Latest value
$6.4M
Q3 2026
Peak value
$11.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $11.4M |
| Q1 2026 | $10.6M |
| Q2 2026 | $8.6M |
| Q3 2026 | $6.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.4M | 6.65M | — | — |
| Q2 2026 | $8.6M | 6.60M | — | — |
| Q1 2026 | $10.6M | 6.73M | — | — |
| Q4 2025 | $11.4M | 6.83M | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M
Other Defender Capital, LLC. positions
PLTR
$59.8MPALANTIR TECHNOLOGIES INC
BRK-A
$50.7MBERKSHIRE HATHAWAY CLASS B
BRK-A
$50.5MBERKSHIRE HATHAWAY CLASS CLASS B
BRK-A
$49.9MBERKSHIRE HATHAWAY INC DEL
BRK-A
$49.9MBERKSHIRE HATHAWAY CLASS B
BRK-A
$47.7MBerkshire Hathaway Inc Cl B
BRK-A
$45.3MPALANTIR TECHNOLOGIES INCLASS A
PLTR
$43.1MPALANTIR TECHNOLOGIES INCLASS A